Darego O Maclayton

Summary

Affiliation: Texas Southern University
Country: USA

Publications

  1. ncbi Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
    Darego O Maclayton
    Texas Southern University College of Pharmacy and Health Sciences, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77004, USA
    Ann Pharmacother 41:235-44. 2007
  2. ncbi Rifaximin for treatment of hepatic encephalopathy
    Darego O Maclayton
    College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA
    Ann Pharmacother 43:77-84. 2009
  3. ncbi Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis
    Darego O Maclayton
    Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA
    Clin Ther 28:1208-16. 2006
  4. ncbi Significant publications on infectious diseases pharmacotherapy in 2007
    Rosa F Yeh
    Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX 77030, USA
    Am J Health Syst Pharm 65:e72-9. 2008

Detail Information

Publications4

  1. ncbi Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
    Darego O Maclayton
    Texas Southern University College of Pharmacy and Health Sciences, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77004, USA
    Ann Pharmacother 41:235-44. 2007
    ..To discuss current and potential treatment options for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA)...
  2. ncbi Rifaximin for treatment of hepatic encephalopathy
    Darego O Maclayton
    College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA
    Ann Pharmacother 43:77-84. 2009
    ..To review the effectiveness and safety of rifaximin in the treatment of hepatic encephalopathy (HE)...
  3. ncbi Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis
    Darego O Maclayton
    Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA
    Clin Ther 28:1208-16. 2006
    ..These patients experienced a longer mean hospital length of stay and increased hospital costs compared with patients with MRSA bacteremia with a vancomycin MIC < or =0.5 microg/mL and uninfected controls...
  4. ncbi Significant publications on infectious diseases pharmacotherapy in 2007
    Rosa F Yeh
    Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX 77030, USA
    Am J Health Syst Pharm 65:e72-9. 2008
    ..Significant publications on infectious diseases (ID) pharmacotherapy in 2007 were compiled and summarized...